Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry

NCT05430971 is registered in ClinicalTrials.gov with Immune Oncology Research Institute as lead sponsor.

NCT NCT05430971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05430971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
Lead sponsor
Immune Oncology Research Institute
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2022
Completion date
July 31, 2032
Enrollment
200 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

blastic plasmacytoid dendritic cell neoplasm (bpdcn)